Transcription factor NF-κB: A sensor for smoke and stress signals

Annals of the New York Academy of Sciences

Volumn 1056, Issue , 2005, Pages 218-233

  Ahn, Kwang Seok ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Gene expression; NF B; Smoke; Stress

Indexed keywords

ANGIOGENIC FACTOR; CARCINOGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHORIONIC GONADOTROPIN; CORTICOSTEROID; CYCLOOXYGENASE 2; CYTOKINE; ENDOTOXIN; FREE RADICAL; GROWTH HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERMEDIN; LUTEINIZING HORMONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR PROMOTER; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ASTHMA; ATHEROSCLEROSIS; BACTERIUM; CANCER; CELL NUCLEUS; CONFERENCE PAPER; CYTOPLASM; DIABETES MELLITUS; GENE EXPRESSION; HUMAN; OSTEOPOROSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STRESS; TH2 CELL; VIRUS;

BACTERIA (MICROORGANISMS);

EID: 29744443925     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1352.026     Document Type: Conference Paper

References (48)

1. AGGARWAL, B.B. 2004. Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
2. AGGARWAL, B.B. 2003. Related articles, links abstract signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756.
3. TAKADA, Y., F.R. KHURI & B.B. AGGARWAL. 2004. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. J. Biol. Chem. 18: 26287-26299.
4. TAKADA, Y. & B.B. AGGARWAL. 2004. TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis. J. Immunol. 173: 1066-1077.
5. TAKADA, Y., X. FANG, M.S. JAMALUDDIN, et al. 2004. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J. Biol. Chem. 279: 39541-3954.
6. OZES, O.N., L.D. MAYO, J.A. GUSTIN, et al. 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
7. YANG, J., Y. LIN, Z. Guo, et al. 2001. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat. Immunol. 2: 620-624.
8. FUNAKOSHI-TAGO, M., Y. SONODA, S. TANAKA, et al. 2003. Related articles, links free full text tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts. J. Biol. Chem. 278: 29359-29365.
9. MANNA, S.K., H.J. ZHANG, T. YAN, et al. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 273: 13245-13254.
10. MANNA, S.K., M.T. Kuo & B.B. AGGARWAL. 1999. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 18:4371-4382.
11. MANNA, S.K., N.K. SAH & B.B. AGGARWAL. 2000. Protein tyrosine kinase p561ck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis. J. Biol. Chem. 275: 13297-13306.
12. TAKADA, Y., A. MUKHOPADHYAY, G.C. KUNDU, et al. 2003. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 278: 24233-24241.
13. MUKHOPADHYAY, A., S.K. MANNA & B.B. AGGARWAL. 2000. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. J. Biol. Chem. 275: 8549-8555.
14. SINGH, S., B.G. DARNAY & B.B. AGGARWAL. 1996. Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271: 31049-31054.
15. FAN, C., Q. Li, D. Ross & J.F. ENGELHARDT. 2003. Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J. Biol. Chem. 278: 2072-2080.
16. DEVARY, Y., C. ROSETTE, J.A. DIDONATO & M. KARIN. 1993. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445.
17. LEE, S.J., A. DIMTCHEV, M.F. LAVIN, et al. 1998. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 17: 1821-1826.
18. Li, N. & M. KARIN. 1998. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95: 13012-13017.
19. GIL, J., J. RULLAS, M.A. GARCIA, et al. 2001. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. Oncogene 20: 385-394.
20. DIGICAYLIOGLU, M. & S.A. LIPTON. 2001. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647.
21. WARIS, G., A. LIVOLSI, V. IMBERT, et al 2003. Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. J. Biol. Chem. 278: 40778-40787.
22. KUMAR, A., Y. TAKADA, A.M. BORIEK & B.B. AGGARWAL. 2004. Nuclear factor-kappaB: its role in health and disease. J. Mol. Med. 82: 434-448.
23. AGGARWAL, B.B., Y. TAKADA, S. SHISHODIA, et al. 2004. Nuclear transcription factor NF-kappa B: role in biology and medicine. Indian J. Exp. Biol. 42: 341-353.
24. SHISHODIA, S. & B.B. AGGARWAL. 2004. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat. Res. 119: 139-173.
25. GARG, A. & B.B. AGGARWAL. 2002. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068.
26. MANNA, S.K. & B.B. AGGARWAL. 1998. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13. J. Biol. Chem. 273: 33333-33341.
27. MANNA, S.K. & B.B. AGGARWAL. 1998. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J. Immunol. 161: 2863-2872.
28. BHATTACHARYYA, S., P. SEN, M. WALLET, et al. 2004. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the P13K/Akt pathway and of IkappaB kinase activity. Blood 104: 1100-1109.
29. MANNA, S.K., A. MUKHOPADHYAY & B.B. AGGARWAL. 2000. Human chorionic gonadotropin suppresses activation of nuclear transcription factor-kappa B and activator protein-1 induced by tumor necrosis factor. J. Biol. Chem. 275: 13307-13314.
30. MANNA, S.K. & B.B. AGGARWAL. 1998. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161: 2873-2880.
31. HAEFFNER, A., N. THIEBLEMONT, O. DEAS, et al. 1997. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes. J. Immunol. 158: 1310-1314.
32. MANNA, S.K., A. MUKHOPADHYAY & B.B. AGGARWAL. 2000. IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis. J. Immunol. 165: 4927-4934.
33. SHISHODIA, S. & B.B. AGGARWAL. 2004. Related articles, links free full text guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 279: 47148-47158.
34. BHARTI, A.C., Y. TAKADA & B.B. AGGARWAL. 2004. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172: 5940-5947.
35. TAKADA, Y. & B.B. AGGARWAL. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J. Biol. Chem. 279: 4750-4759.
36. TAKADA, Y. & B.B. AGGARWAL. 2003. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J. Immunol. 171: 3278-3286.
37. SHISHODIA, S., S. MAJUMDAR, S. BANERJEE & B.B. AGGARWAL. 2003. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63: 4375-4383.
38. ASHIKAWA, K., S. MAJUMDAR, S. BANERJEE, et al. 2002. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 169: 6490-6497.
39. BHARTI, A.C., N. DONATO, S. SINGH & B.B. AGGARWAL. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053-1062.
40. MAJUMDAR, S., B. LAMOTHE & B.B. AGGARWAL. 2002. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester. J. Immunol. 168: 2644-2651.
41. MANNA, S.K., N.K. SAH, R.A. NEWMAN, et al. 2000. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res. 60: 3838-3847.
42. CHAINY, G.B., S.K. MANNA, M.M. CHATURVEDI & B.B. AGGARWAL. 2000. Related articles, links abstract anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 19: 2943-2950.
43. MANNA, S.K., A. MUKHOPADHYAY & B.B. AGGARWAL. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164: 6509-6519.
44. MANNA, S.K., A. MUKHOPADHYAY, N.T. VAN & B.B. AGGARWAL. 1999. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J. Immunol. 163: 6800-6809.
45. KUMAR, A., S. DHAWAN & B.B. AGGARWAL. 1998. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17: 913-918.
46. CHATURVEDI, M.M., A. KUMAR, E.G. DARNAY, et al. 1997. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J. Biol. Chem. 272: 30129-30134.
47. SHISHODIA, S. & B.B. AGGARWAL. 2004. Nuclear factor-kappaB: a friend or a foe in cancer? Biochem. Pharmacol. 68: 1071-1080.
48. ANTO, R.J., A. MUKHOPADHYAY, S. SHISHODIA, et al. 2002. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23: 1511-1518.